Aperio Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$3.62M Buy
21,953
+599
+3% +$98.9K 0.01% 966
2020
Q3
$3.05M Sell
21,354
-1,712
-7% -$244K 0.01% 921
2020
Q2
$2.55M Sell
23,066
-5,964
-21% -$658K 0.01% 1001
2020
Q1
$2.9M Sell
29,030
-2,276
-7% -$227K 0.01% 860
2019
Q4
$4.67M Sell
31,306
-7,223
-19% -$1.08M 0.02% 758
2019
Q3
$4.94M Sell
38,529
-144
-0.4% -$18.5K 0.02% 714
2019
Q2
$5.51M Buy
38,673
+14,434
+60% +$2.06M 0.02% 677
2019
Q1
$3.47M Buy
24,239
+8,132
+50% +$1.16M 0.02% 816
2018
Q4
$2M Buy
16,107
+4,451
+38% +$552K 0.01% 988
2018
Q3
$1.96M Buy
11,656
+587
+5% +$98.7K 0.01% 1073
2018
Q2
$1.91M Buy
11,069
+1,787
+19% +$308K 0.01% 1051
2018
Q1
$1.4M Sell
9,282
-5,773
-38% -$872K 0.01% 1147
2017
Q4
$2.03M Buy
15,055
+9,073
+152% +$1.22M 0.01% 978
2017
Q3
$875K Sell
5,982
-135
-2% -$19.7K ﹤0.01% 1350
2017
Q2
$951K Sell
6,117
-513
-8% -$79.8K 0.01% 1262
2017
Q1
$962K Buy
6,630
+122
+2% +$17.7K 0.01% 1190
2016
Q4
$709K Sell
6,508
-7,613
-54% -$829K 0.01% 1314
2016
Q3
$1.72M Sell
14,121
-5,671
-29% -$689K 0.01% 894
2016
Q2
$2.8M Buy
19,792
+1,271
+7% +$180K 0.02% 691
2016
Q1
$2.42M Buy
18,521
+4,092
+28% +$534K 0.02% 713
2015
Q4
$2.03M Buy
14,429
+7,620
+112% +$1.07M 0.02% 749
2015
Q3
$904K Sell
6,809
-427
-6% -$56.7K 0.01% 1017
2015
Q2
$1.27M Buy
7,236
+2,712
+60% +$477K 0.01% 877
2015
Q1
$782K Buy
4,524
+1,074
+31% +$186K 0.01% 1048
2014
Q4
$565K Buy
3,450
+470
+16% +$77K 0.01% 1158
2014
Q3
$478K Buy
2,980
+475
+19% +$76.2K 0.01% 1162
2014
Q2
$368K Buy
2,505
+617
+33% +$90.6K 0.01% 1278
2014
Q1
$262K Buy
+1,888
New +$262K ﹤0.01% 1713
2013
Q4
Hold
0
1670